Are your kidneys Ok? Detect early to protect kidney health

IF 12.6 1区 医学 Q1 UROLOGY & NEPHROLOGY Kidney international Pub Date : 2025-03-01 Epub Date: 2025-02-19 DOI:10.1016/j.kint.2024.12.006
Joseph A. Vassalotti , Anna Francis , Augusto Cesar Soares dos Santos Jr. , Ricardo Correa-Rotter , Dina Abdellatif , Li-Li Hsiao , Stefanos Roumeliotis , Agnes Haris , Latha A. Kumaraswami , Siu-Fai Lui , Alessandro Balducci , Vassilios Liakopoulos , World Kidney Day Joint Steering Committee
{"title":"Are your kidneys Ok? Detect early to protect kidney health","authors":"Joseph A. Vassalotti ,&nbsp;Anna Francis ,&nbsp;Augusto Cesar Soares dos Santos Jr. ,&nbsp;Ricardo Correa-Rotter ,&nbsp;Dina Abdellatif ,&nbsp;Li-Li Hsiao ,&nbsp;Stefanos Roumeliotis ,&nbsp;Agnes Haris ,&nbsp;Latha A. Kumaraswami ,&nbsp;Siu-Fai Lui ,&nbsp;Alessandro Balducci ,&nbsp;Vassilios Liakopoulos ,&nbsp;World Kidney Day Joint Steering Committee","doi":"10.1016/j.kint.2024.12.006","DOIUrl":null,"url":null,"abstract":"<div><div>Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day we assert that case-finding in high-risk populations, or even population level screening, can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic and simple to test for, and recent paradigm shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, health care funding, health care infrastructure, and health care professional and population awareness of kidney disease. Coordinated efforts by major kidney nongovernmental organizations to prioritize the kidney health agenda for governments and aligning early detection efforts with other current programs will maximize efficiencies.</div></div>","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"107 3","pages":"Pages 370-377"},"PeriodicalIF":12.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney international","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0085253824009177","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day we assert that case-finding in high-risk populations, or even population level screening, can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic and simple to test for, and recent paradigm shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, health care funding, health care infrastructure, and health care professional and population awareness of kidney disease. Coordinated efforts by major kidney nongovernmental organizations to prioritize the kidney health agenda for governments and aligning early detection efforts with other current programs will maximize efficiencies.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
你的肾脏还好吗?及早发现,保护肾脏健康
早期发现肾脏疾病可以保护肾脏健康,预防肾脏疾病进展及相关并发症,降低心血管疾病风险,降低死亡率。我们必须问“你的肾脏还好吗?”用血清肌酐评估肾功能,用尿白蛋白评估肾脏和内皮损伤。对慢性肾脏疾病(CKD)的病因和危险因素的评估包括糖尿病的检测和血压和体重指数的测量。在这个世界肾脏日,我们主张在高危人群中发现病例,甚至在人群水平上进行筛查,可以减轻全球肾脏疾病的负担。早期CKD无症状且易于检测,最近的CKD治疗模式转变,如葡萄糖共转运蛋白-2抑制剂显著改善了结果,有利于筛查或病例发现项目的成本-效益分析。尽管如此,仍然存在许多障碍,包括资源分配、卫生保健资金、卫生保健基础设施以及卫生保健专业人员和人口对肾脏疾病的认识。主要的肾脏非政府组织协调努力,优先考虑各国政府的肾脏健康议程,并将早期检测工作与其他现有项目结合起来,将最大限度地提高效率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Kidney international
Kidney international 医学-泌尿学与肾脏学
CiteScore
23.30
自引率
3.10%
发文量
490
审稿时长
3-6 weeks
期刊介绍: Kidney International (KI), the official journal of the International Society of Nephrology, is led by Dr. Pierre Ronco (Paris, France) and stands as one of nephrology's most cited and esteemed publications worldwide. KI provides exceptional benefits for both readers and authors, featuring highly cited original articles, focused reviews, cutting-edge imaging techniques, and lively discussions on controversial topics. The journal is dedicated to kidney research, serving researchers, clinical investigators, and practicing nephrologists.
期刊最新文献
Dynamic control of Na-Cl cotransporter by kidney-specific with-no-lysine 1 kinase: a biphasic response to K+ via condensate signaling Giving monocytes their due: how CD47–SIRP-α reframes allograft rejection When YAP is hyperactivated in podocytes, it persistently “yaps,” disrupting the quiescence of neighboring glomerular cells Aldehyde dehydrogenase 1 A1 regulates the transcription of PD-L1 and its targeting with disulfiram together with PD-L1 immunotherapy synergistically delays cyst growth in ADPKD Nephrotic syndrome genomic discovery in the Mass General Brigham Biobank identifies monoallelic MEFV variants as a risk factor for focal segmental glomerulosclerosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1